摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-硝基-3H-1,3-苯并恶唑-2-酮 | 3889-13-2

中文名称
5-硝基-3H-1,3-苯并恶唑-2-酮
中文别名
5-硝基-3H-苯并恶唑-2-酮;5-硝基-1,3-苯并恶唑-2(3H)-酮;2(3H)-苯并恶唑酮,5-硝基-
英文名称
5-nitro-3H-benzooxazol-2-one
英文别名
5-nitrobenzo[d]oxazol-2(3H)-one;5-Nitrobenzoxazolon;5-nitro-2(3H)-benzoxazolone;5-nitro-3H-1,3-benzoxazol-2-one;5-nitro-1,3-benzoxazol-2(3H)-one
5-硝基-3H-1,3-苯并恶唑-2-酮化学式
CAS
3889-13-2
化学式
C7H4N2O4
mdl
MFCD01929029
分子量
180.12
InChiKey
UTQPEXLRBRAERQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    242 °C
  • 密度:
    1.580±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    84.2
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302

SDS

SDS:31d5c36df8fdf5c3a24bf01b03bb8f00
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Nitro-3H-1,3-benzoxazol-2-one
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5-Nitro-3H-1,3-benzoxazol-2-one
CAS number: 3889-13-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H4N2O4
Molecular weight: 180.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    5-硝基-3H-1,3-苯并恶唑-2-酮 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 反应 0.5h, 生成 5-溴-2(3H)-苯并噁唑酮
    参考文献:
    名称:
    3-氨基烷基-2-苯并恶唑啉酮。
    摘要:
    DOI:
    10.1021/jm00315a027
  • 作为产物:
    描述:
    2-氨基-4-硝基苯酚二氯甲烷 为溶剂, 以78%的产率得到5-硝基-3H-1,3-苯并恶唑-2-酮
    参考文献:
    名称:
    Alpha2C adrenoreceptor agonists
    摘要:
    在其多种实施形式中,本发明涉及一类新型的苯基吗啡啶和苯基硫代吗啡啶化合物,这些化合物可用作α2C肾上腺素受体激动剂,包含这些化合物的药物组合物,以及使用这些化合物或药物组合物治疗、预防、抑制或改善与α2C肾上腺素受体激动剂相关的一种或多种疾病的方法。
    公开号:
    US20070093477A1
点击查看最新优质反应信息

文献信息

  • Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
    申请人:N30 Pharmaceuticals, Inc.
    公开号:US09138427B2
    公开(公告)日:2015-09-22
    The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    本发明涉及S-亚硝基谷胱甘肽还原酶(GSNOR)的抑制剂,包括这种GSNOR抑制剂的药物组合物,以及制备和使用这些药物的方法。
  • Synthesis of Benz[<i>d</i>]oxazolones Involving Concomitant Acetyl Migration from Oxygen to Nitrogen
    作者:Sibdas Ray、Sukla Ghosh
    DOI:10.1080/00397910903245158
    日期:2010.7.27
    Heating of o-acetoxybenzoyl azides 6–10 in toluene leads to the Curtius reaction, which, when followed by closure of oxazolone ring with concomitant migration of acetyl group from oxygen to nitrogen, produces 3-acetoxybenz[d]oxazol-2(3H)-ones 11–15, which undergo hydrolysis with hot dilute hydrochloric acid to furnish benz[d]oxazol-2(3H)-ones 17–21. Thermal reaction of 2-hydroxy-5-nitrobenzoyl azide
    在甲苯中加热邻乙酰氧基苯甲酰叠氮化物 6-10 导致 Curtius 反应,随后恶唑酮环闭合,同时乙酰基从氧迁移到氮,生成 3-乙酰氧基苯并[d]恶唑-2(3H) -ones 11-15,用热的稀盐酸水解,得到苯并[d]恶唑-2(3H)-ones 17-21。2-羟基-5-硝基苯甲酰叠氮化物 (22) 在甲苯中的热反应最终产生 5-硝基苯并[d]恶唑-2(3H)-酮 (20) 和 5-硝基苯并[d]异恶唑-3(2H)的混合物)-一 (23)。
  • General and efficient synthesis of benzoxazol-2(3H)-ones: evolution of their anti-cancer and anti-mycobacterial activities
    作者:K. Indrasena Reddy、C. Aruna、K. Sudhakar Babu、V. Vijayakumar、M. Manisha、J. Padma Sridevi、P. Yogeeswari、D. Sriram
    DOI:10.1039/c4ra07123a
    日期:——

    A novel class of benzo[d]oxazol-2(3H)-one derivatives has been synthesized and their in vitro cytotoxicity against human pancreatic adenocarcinoma and human non-small cell lung carcinoma cancer cell lines was evaluated.

    已经合成了一类新型的苯并[d]恶唑-2(3H)-酮衍生物,并评估了它们对人类胰腺腺癌和非小细胞肺癌细胞系的体外细胞毒性。

  • [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS D'IMMUNODÉFICIENCE HUMAINE
    申请人:VIIV HEALTHCARE (NO 5) LTD
    公开号:WO2016172425A1
    公开(公告)日:2016-10-27
    Compounds of Formulas I-VI, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth. Formula I is exemplified below: Formula (i)
    公式I-VI的化合物,包括其药用可接受的盐,以及用于治疗人类免疫缺陷病毒(HIV)感染的组合物和方法。公式I如下所示:公式(i)
  • Zwitterionic Ring-Opened Oxyphosphonium Species from the Ph<sub>3</sub>P–I<sub>2</sub> Mediated Reactions of Benzo[<i>d</i>]oxazol-2(3<i>H</i>)-ones with Secondary Amines
    作者:Mookda Pattarawarapan、Nittaya Wiriya、Saranphong Yimklan、Sirilak Wangngae、Wong Phakhodee
    DOI:10.1021/acs.joc.0c00211
    日期:2020.5.1
    Ph3P-I2-mediated reactions of benzo[d]oxazol-2(3H)-ones with acyclic secondary amines. The structure of one of these compounds was unambiguously confirmed by single-crystal X-ray analysis. Thermolysis of the betaines gave rise to 2-dialkylaminobenzoxazoles with concomitant loss of triphenylphosphine oxide, suggesting their possible role as intermediates in an alternative reaction path.
    代替预期的取代的2-氨基苯并[d]恶唑,首次从Ph3P-I2介导的苯并[d]恶唑-2(3H)-酮与无环仲醇的反应中分离了相对稳定的开环氧phosph甜菜碱胺类。通过单晶X射线分析清楚地证实了这些化合物之一的结构。甜菜碱的热解产生了2-二烷基氨基苯并恶唑,同时伴随着三苯基膦氧化物的损失,表明它们在替代反应路径中作为中间体的可能作用。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) 钙离子载体A23187半镁盐 荧光增白剂EBF 苯并恶唑胺 苯并恶唑的取代物 苯并恶唑甲磺酰氯 苯并恶唑基-2-甲酰基-S-乙基-异缩氨基硫脲 苯并恶唑-2-羧酸酰肼 苯并恶唑-2-磺酸 苯并恶唑-2-甲酸 苯并恶唑-2-甲磺酸钠 苯并恶唑-2-乙酸 苯并恶唑 苯并噁唑-5-甲酸 苯并噁唑-2-羧酸乙酯 苯并噁唑-2-甲醛 苯并噁唑,4,7-二氯-2-(氯甲基)- 苯并噁唑,2-叠氮- 苯并噁唑,2-(氯甲基)-4,7-二氟- 苯并[d]恶唑-7-甲酸甲酯 苯并[d]恶唑-5-硼酸频哪醇酯 苯并[d]噁唑-6-甲醛 苯并[d]噁唑-2-羧酸甲酯 苯并[d]噁唑-2-甲醇 苯并[D]恶唑-7-胺 苯并[D]噁唑-4-基氨基甲酸叔丁酯 苯并[D]噁唑-2-羧酸钾 苯并-13C6-噁唑 离子载体 碘化二氢2-[3-(5,6-二氯-1,3-二乙基-1,3--2H-苯并咪唑-2-亚基)丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 硫代偏糖醛 甲酰胺,N-乙基-N-[6-[(3-甲酰基苯氧基)甲基]-2-苯并噁唑基]- 甲酰胺,N-[6-(溴甲基)-2-苯并噁唑基]-N-乙基- 甲基硫酸1-甲基-8-[(甲基氨基甲酰)氧代]喹啉正离子 甲基6-氨基-1,3-苯并恶唑-2-羧酸酯 甲基2-氨基-1,3-苯并恶唑-5-羧酸酯 甲基1,3-苯并恶唑-2-基乙酸酯 甲基-2-乙基-1,3-苯并唑-5-羧酸乙酯 甲基-1,3-苯并唑-5-羧酸乙酯 环戊二烯并[e][1,3]恶嗪-5,6-二胺 环戊二烯并[d][1,3]恶嗪-6,7-二胺 溴氯唑酮 溴化二氢2-[3-[1-[4-[(乙酰氨基)磺基基]丁基]-5,6-二氯-3-乙基-1,3--2H-苯并咪唑-2-亚基]丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 氰基二硫代亚氨酸(6-氯-2-氧代-3(2H)-苯并恶唑基)甲基甲基酯 氰基-二硫代亚氨酸甲基(2-氧代-3(2H)-苯并恶唑基)甲基酯 氯唑沙宗-2-13C-3-15N-羟基-18O 氯唑沙宗 氯化3-乙基-2-[2-(1-乙基-2,5-二甲基-1H-吡咯-3-基)乙烯基]苯并恶唑翁盐 昂唑司特 拂来星-d2